- Home
- QRVO vs PRCT Comparison
QRVO vs PRCT Comparison
Compare QRVO & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QRVO
- PRCT
- Stock Information
- Founded
- QRVO 1957
- PRCT 2009
- Country
- QRVO United States
- PRCT United States
- Employees
- QRVO N/A
- PRCT N/A
- Industry
- QRVO Semiconductors
- PRCT Medical Specialities
- Sector
- QRVO Technology
- PRCT Health Care
- Exchange
- QRVO Nasdaq
- PRCT Nasdaq
- Market Cap
- QRVO 6.3B
- PRCT 5.3B
- IPO Year
- QRVO 1997
- PRCT 2021
- Fundamental
- Price
- QRVO $70.85
- PRCT $81.17
- Analyst Decision
- QRVO Hold
- PRCT Strong Buy
- Analyst Count
- QRVO 18
- PRCT 7
- Target Price
- QRVO $96.31
- PRCT $97.86
- AVG Volume (30 Days)
- QRVO 3.4M
- PRCT 592.2K
- Earning Date
- QRVO 01-29-2025
- PRCT 10-28-2024
- Dividend Yield
- QRVO N/A
- PRCT N/A
- EPS Growth
- QRVO N/A
- PRCT N/A
- EPS
- QRVO N/A
- PRCT N/A
- Revenue
- QRVO $3,948,029,000.00
- PRCT $199,843,000.00
- Revenue This Year
- QRVO N/A
- PRCT $67.07
- Revenue Next Year
- QRVO $4.55
- PRCT $40.64
- P/E Ratio
- QRVO N/A
- PRCT N/A
- Revenue Growth
- QRVO 26.11
- PRCT 71.71
- 52 Week Low
- QRVO $64.54
- PRCT $39.48
- 52 Week High
- QRVO $130.99
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- QRVO 47.96
- PRCT 33.77
- Support Level
- QRVO $68.10
- PRCT $79.30
- Resistance Level
- QRVO $70.84
- PRCT $92.92
- Average True Range (ATR)
- QRVO 2.31
- PRCT 4.06
- MACD
- QRVO 0.85
- PRCT -1.87
- Stochastic Oscillator
- QRVO 87.28
- PRCT 9.21
About QRVO Qorvo Inc.
Qorvo represents the combined entity of RF Micro Devices and TriQuint Semiconductor, which merged in January 2015. The company specializes in radio frequency filters, power amplifiers, and front-end modules used in many of the world's most advanced smartphones. Qorvo also has a suite of products sold into a variety of nonsmartphone end markets, such as wireless base stations, cable TV and networking equipment, and infrastructure and military applications.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.